Recent 8-K filings for NPHC

• September 2, 2026, 2:38 PM ET other material materiality 0.85 neutral item 5.01

  Nutra Pharma changes control; Pure Raw Supplies gains 62.63% voting power via Series B gift

  Rik Deitsch transferred 12,000,000 Series B Preferred shares to Pure Raw Supplies, LLC on Aug 21, 2026.

• September 3, 2025, 7:59 PM ET other material materiality 0.80 negative item 4.01item 9.01 ◈ Auditor Changes ×2

  Nutra Pharma Corp. changes certifying accountant: Marcum LLP resigns, Astra Audit & Advisory engaged

  Marcum LLP resigned as independent auditor on March 27, 2024, after only reviewing Q2 and Q3 2022 Form 10-Qs.

• March 22, 2024, 7:59 PM ET leadership materiality 0.80 negative item 5.02item 8.01item 7.01item 9.01 ◈ executive_change ×2

  Nutra Pharma CEO Rik Deitsch resigns amid SEC settlement; Dr. Michael Flax appointed CEO/CFO/Chairman

  Rik Deitsch resigned as CEO, Director, Chairman, and CFO effective March 19, 2024, due to SEC settlement.

• August 4, 2022, 7:59 PM ET other material materiality 0.40 neutral item 4.01item 9.01

  Nutra Pharma appoints Marcum LLP as new independent auditor after Rotenberg merger

  Rotenberg, prior auditor, combined with Marcum LLP in Feb 2022; continued as subsidiary through Q1 2022.

Materiality & sentiment trend

Max materiality 0.85 · Median 0.80 · Most common event other_material

0 positive 2 negative 2 neutral

source · NPHC on sec.gov